Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14337698 | 1.00 | TDP1 (0.52) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL14645485 | 0.93 | TDP1 (0.50) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL13321986 | 0.93 | TDP1 (0.50) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL1356320 | 0.91 | ALDH1A1 (0.50) | TDP1MAPK1ALDH1A1CYP3A4CA2 | |
| SCHEMBL18493494 | 0.91 | TDP1 (0.46) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL17203010 | 0.91 | TDP1 (0.46) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL1357035 | 0.91 | ALDH1A1 (0.50) | TDP1MAPK1ALDH1A1CYP3A4CA2 | |
| SCHEMBL15496895 | 0.89 | MAPK1 (0.48) | TDP1MAPK1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL20173388 | 0.87 | KDM4E (0.52) | TDP1MAPK1KDM4EALDH1A1MEN1 | |
| SCHEMBL28700702 | 0.86 | KDM1A (0.46) | TDP1MAPK1KDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12532662-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2026-01-20 | — | — | US | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| EP-4019522-B1 | NEW DERIVATIVES OF PYRROLOPYRROLE CYANINES AND USES THEREOF | CENTRE NAT RECH SCIENT (FR) | 2023-09-27 | — | — | EP | disclosed |
| US-20230287001-A1 | Organic Semiconducting Compounds | RAYNERGY TEK INC (TW) | 2023-09-14 | — | — | US | disclosed |
| US-20230287001-A1 | Organic Semiconducting Compounds | RAYNERGY TEK INC (TW) | 2023-09-14 | — | — | US | disclosed |
| US-20230287001-A1 | Organic Semiconducting Compounds | RAYNERGY TEK INC (TW) | 2023-09-14 | — | — | US | disclosed |
| US-20220320445-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC. (TW) | 2022-10-06 | — | — | US | disclosed |
| WO-2022144228-A1 | NEW DERIVATIVES OF PYRROLOPYRROLE CYANINES AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-07-07 | — | — | WO | disclosed |
| EP-0743309-B1 | o-Hydroxyphenyl-s-triazines as UV stabilisers | CIBA SC HOLDING AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| US-20030082402-A1 | Electroluminescent devices having diarylanthracene polymers | EASTMAN KODAK COMPANY | 2003-05-01 | — | — | US | disclosed |
| EP-1288276-A1 | Electroluminescent devices having diarylanthracene polymers | EASTMAN KODAK COMPANY (US) | 2003-03-05 | — | — | EP | disclosed |
| EP-0654469-B1 | Stabilised polymers containing o-hydroxyphenyl-s-triazines | CIBA SC HOLDING AG (CH) | 2001-08-22 | — | — | EP | disclosed |
| EP-1096251-A1 | FILM RESPONSIVE TO BICARBONATE ION | TOKUYAMA CORPORATION (JP) | 2001-05-02 | — | — | EP | disclosed |
| US-5760111-A | TEXTILE STABILIZERS WITH PHOTOSTABILIZERS, OXIDATION OR HEAT RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5688995-A | SUNSCREEN AGENTS | CIBA-GEIGY CORPORATION (US) | 1997-11-18 | — | — | US | disclosed |
| US-5591850-A | STABILIZERS FOR TEXTILE FIBERS, COSMETIC SUNSCREENS | CIBA-GEIGY CORPORATION (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0743309-A1 | o-Hydroxyphenyl-s-triazines as UV stabilisers | CIBA-GEIGY AG (CH) | 1996-11-20 | — | — | EP | disclosed |
| EP-0654469-A1 | O-Hydroxyphenyl-s-triazines as stabilisers for polymers | CIBA-GEIGY AG (CH) | 1995-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839155-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | TDP1 2851/4885MAPK1 2031/4885KDM4E 704/4885 |
| US-12532662-B2 | Organic semiconducting compounds | OXER1, BMI1, CRY2 | TDP1 3413/4885MAPK1 887/4885KDM4E 1877/4885 |
| US-20230287001-A1 | Organic Semiconducting Compounds | OCIAD2, OCIAD1, OSTC | TDP1 2851/4885MAPK1 2031/4885KDM4E 704/4885 |
| US-20220320445-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | OCIAD2, OCIAD1, OSTC | TDP1 2851/4885MAPK1 2031/4885KDM4E 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.